Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Company · United States
Declared costs: €100K+ a year · in the register since 2011
Other · Belgium
Declared costs: €300K+ a year · in the register since 2012
Medicinal products for human use · Fluorinated gases regulation
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
Baxter · filed 27 Apr 2021 · source
Baxter is a global healthcare company with a leading portfolio of critical care, nutrition, renal, hospital and surgical products and we are driven by our mission to save and sustain lives. We stand ready to partner with EU policy-makers during the on-going process to modernise the EU’s regulatory environment for pharmaceuticals.
European Respiratory Society · filed 27 Apr 2021 · source
ERS appreciates the opportunity to contribute to this roadmap on the revision of the General Pharmaceutical legislation (namely Directive 2001/83/EC1 and Regulation (EC) No 726/20042). Join the dots: Legislation must foster medical advancement not hamper it.
European Respiratory Society · filed 8 Nov 2023 · source
Answer to the request for feedback on the revision of the EU general pharmaceutical legislation The European Respiratory Society, (ERS) is one of the leading medical organisations in the respiratory field, with a growing membership spanning over 160 countries.
Baxter · filed 28 Jun 2022 · source
Baxter is a leading global pharmaceutical & medical device company committed to delivering life-saving and sustaining products. We have been working with clinicians and hospitals across Europe for years to provide anaesthetic agents (inhaled & intravenous) that allow clinical treatment to be tailored to specific patient needs.
European Respiratory Society · filed 29 Jun 2022 · source
ERS submission to F-gases revision The European Respiratory Society welcomes and supports the proposed revision of the F-gases regulation by the European Commission. The scale of climate change impact on the planetary and human health, that is now, irreversible necessitates such ambition. The World Health Organization (WHO) has warned that climate change is the biggest global threat to humanity in the 21st century.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.